These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14707272)

  • 1. E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model.
    Zhou Z; Zhou RR; Guan H; Bucana CD; Kleinerman ES
    Mol Cancer Ther; 2003 Dec; 2(12):1313-9. PubMed ID: 14707272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16.
    Zhou RR; Jia SF; Zhou Z; Wang Y; Bucana CD; Kleinerman ES
    Cancer Gene Ther; 2002 May; 9(5):407-13. PubMed ID: 11961663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs.
    Zhou Z; Jia SF; Hung MC; Kleinerman ES
    Cancer Res; 2001 Apr; 61(8):3394-8. PubMed ID: 11309298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma.
    Schadler KL; Zweidler-McKay PA; Guan H; Kleinerman ES
    Clin Cancer Res; 2010 Feb; 16(3):848-56. PubMed ID: 20103680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
    Guan H; Zhou Z; Gallick GE; Jia SF; Morales J; Sood AK; Corey SJ; Kleinerman ES
    Mol Cancer Ther; 2008 Jul; 7(7):1807-16. PubMed ID: 18644993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas.
    Yu L; Su B; Hollomon M; Deng Y; Facchinetti V; Kleinerman ES
    Cancer Res; 2010 Feb; 70(4):1334-43. PubMed ID: 20124484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic adenovirus-mediated E1A gene therapy induces tumor-cell apoptosis and reduces tumor angiogenesis leading to inhibition of hepatocellular carcinoma growth in animal model.
    Ye Z; Wang X; Hao S; Zhong J; Xiang J; Yang J
    Cancer Biother Radiopharm; 2006 Jun; 21(3):225-34. PubMed ID: 16918299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF(165), but not VEGF(189), stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo.
    Zhou Z; Reddy K; Guan H; Kleinerman ES
    Mol Cancer Res; 2007 Nov; 5(11):1125-32. PubMed ID: 18025258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model.
    Chernoguz A; Crawford K; Donovan E; Vandersall A; Berglund C; Cripe TP; Frischer JS
    J Surg Res; 2012 Mar; 173(1):1-9. PubMed ID: 21658718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus 5 E1a-mediated gene therapy for human ovarian cancer cells in vitro and in vivo.
    Zang RY; Shi DR; Lu HJ; Cai SM; Lu DR; Zhang YJ; Qin HL
    Int J Gynecol Cancer; 2001; 11(1):18-23. PubMed ID: 11285029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
    Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature.
    Reddy K; Cao Y; Zhou Z; Yu L; Jia SF; Kleinerman ES
    Angiogenesis; 2008; 11(3):257-67. PubMed ID: 18344025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo.
    Guan H; Jia SF; Zhou Z; Stewart J; Kleinerman ES
    Clin Cancer Res; 2005 Mar; 11(5):2008-17. PubMed ID: 15756027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E1A specifically enhances sensitivity to topoisomerase IIalpha targeting anticancer drug by up-regulating the promoter activity.
    Zhou Z; Guan H; Kleinerman ES
    Mol Cancer Res; 2005 May; 3(5):271-5. PubMed ID: 15886298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma.
    Jia SF; Duan X; Worth LL; Guan H; Kleinerman ES
    Cancer Gene Ther; 2006 Oct; 13(10):948-57. PubMed ID: 16763609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature.
    Lee TH; Bolontrade MF; Worth LL; Guan H; Ellis LM; Kleinerman ES
    Int J Cancer; 2006 Aug; 119(4):839-46. PubMed ID: 16557578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
    Liao Y; Zou YY; Xia WY; Hung MC
    Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung.
    Zhou Z; Stewart KS; Yu L; Kleinerman ES
    Angiogenesis; 2011 May; 14(2):125-33. PubMed ID: 21184173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.